Breast Cancer Therapeutics Market Is Expected to Rise Rapidly to US$ 7,853.1 Million by the End of 2023
Even as the breast cancer epidemic shows no signs of decelerating, the burden of this diseases has reached record levels. This burden can be put into numbers: In 2012 alone, 1,676,600 new cases of breast cancer were diagnosed among women; in the same year, 521,900 women were reported to have died of the disease. These numbers reflect the sheer burden that the disease is putting on healthcare agencies (both public and private) and governments across the world. This makes a...
View full press release